Beverly A. Mock

B Cell–Specific Deficiencies in mTOR Limit Humoral Immune Responses

Ke Zhang, C. Snapper, R. Casellas, 2013, The Journal of Immunology.

Molecular Carcinogenesis

Xingmin Feng, Jichun Chen, Vishal Thovarai, 2020 .

Cdkn2a, the cyclin-dependent kinase inhibitor encoding p16INK4a and p19ARF, is a candidate for the plasmacytoma susceptibility locus, Pctr1.

E. Ramsay, B. Mock, S. Zhang, 1998, Proceedings of the National Academy of Sciences of the United States of America.

Hypomorphic mTOR Downregulates CDK6 and Delays Thymic Pre-T LBL Tumorigenesis

R. M. Simpson, J. Testa, W. Dubois, 2020, Molecular Cancer Therapeutics.